Your email has been successfully added to our mailing list.

×
-0.00193548387096777 0 -0.000537634408602211 0.018494623655914 0.0214516129032258 0.0533333333333333 0.0698924731182795 0.0698924731182795
Stock impact report

ENDRA Life Sciences continues post-IPO stumble, down 14% [Seeking Alpha]

ENDRA Life Sciences Inc. (NDRA) 
Company Research Source: Seeking Alpha
ENDRA Life Sciences continues post-IPO stumble, down 14%Thinly traded nano capENDRA Life Sciences (NDRA-14%) adds to its retreat sincedebuting at $5/unit on May 9. Each unit consisted of one share of common stock and one five-year warrant to purchase one share of common at $6.25. Shares are currently exchanging hands at $1.93.The company develops technologies that improve the performance of ultrasound systems.See all stocks on the move »Now read:Update On Restoration Robotics: HAIR Will Need More Time To Grow » Show less Read more
Impact Snapshot
Event Time:
NDRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for NDRA alerts
Opt-in for
NDRA alerts

from News Quantified
Opt-in for
NDRA alerts

from News Quantified